76 related articles for article (PubMed ID: 27465885)
21. Risk of recurrence of resected stage I non-small cell lung cancer in elderly patients as compared with younger patients.
Goodgame B; Viswanathan A; Zoole J; Gao F; Miller CR; Subramanian J; Meyers BF; Patterson AG; Govindan R
J Thorac Oncol; 2009 Nov; 4(11):1370-4. PubMed ID: 19692932
[TBL] [Abstract][Full Text] [Related]
22. Feasibility and benefit of concurrent chemoradiotherapy for elderly patients with uterine cervical cancer.
Nosaka K; Shibata K; Utsumi F; Yoshida K; Niimi K; Sekiya R; Suzuki S; Kajiyama H; Kikkawa F
Tumori; 2016 Dec; 102(6):600-605. PubMed ID: 27443893
[TBL] [Abstract][Full Text] [Related]
23. Open versus laparoscopic pelvic lymph node dissection in early stage cervical cancer: no difference in surgical or disease outcome.
van de Lande J; von Mensdorff-Pouilly S; Lettinga RG; Piek JM; Verheijen RH
Int J Gynecol Cancer; 2012 Jan; 22(1):107-14. PubMed ID: 21857347
[TBL] [Abstract][Full Text] [Related]
24. Chemoradiation for invasive cervical cancer in elderly patients: outcomes and morbidity.
Goodheart M; Jacobson G; Smith BJ; Zhou L
Int J Gynecol Cancer; 2008; 18(1):95-103. PubMed ID: 17466049
[TBL] [Abstract][Full Text] [Related]
25. About invasive cervical cancer: a French population based study between 1998 and 2010.
Lorin L; Bertaut A; Hudry D; Beltjens F; Roignot P; Bone-Lepinoy MC; Douvier S; Arveux P
Eur J Obstet Gynecol Reprod Biol; 2015 Aug; 191():1-6. PubMed ID: 26004674
[TBL] [Abstract][Full Text] [Related]
26. Stage IIA1 versus stage IIA2 cervical cancer: does the new staging criteria predict survival?
Garg G; Shah JP; Toy EP; Christensen C; Deppe G; Asaad R; Morris RT
Int J Gynecol Cancer; 2011 May; 21(4):711-6. PubMed ID: 21412165
[TBL] [Abstract][Full Text] [Related]
27. The Effect of Country of Birth on the Pattern of Disease and Survival From Cervical Cancer.
Moss E; Askew S; Cheung S; Dawson P; Singh K; Redman CW; Pearmain P
J Low Genit Tract Dis; 2016 Jan; 20(1):38-43. PubMed ID: 26579839
[TBL] [Abstract][Full Text] [Related]
28. Impact of facility volume on therapy and survival for locally advanced cervical cancer.
Lin JF; Berger JL; Krivak TC; Beriwal S; Chan JK; Sukumvanich P; Monk BJ; Richard SD
Gynecol Oncol; 2014 Feb; 132(2):416-22. PubMed ID: 24333361
[TBL] [Abstract][Full Text] [Related]
29. Can chemotherapy boost the survival benefit of adjuvant radiotherapy in early stage cervical cancer with intermediate risk factors? A population based study.
Mahmoud O; Hathout L; Shaaban SG; Elshaikh MA; Beriwal S; Small W
Gynecol Oncol; 2016 Dec; 143(3):539-544. PubMed ID: 27769525
[TBL] [Abstract][Full Text] [Related]
30. Thromboembolic event as a prognostic factor for the survival of patients with stage IIIB cervical cancer.
Renni MJ; Russomano FB; Mathias LF; Koch HA
Int J Gynecol Cancer; 2011 May; 21(4):706-10. PubMed ID: 21546873
[TBL] [Abstract][Full Text] [Related]
31. Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
Bingham B; Orton A; Boothe D; Stoddard G; Huang YJ; Gaffney DK; Poppe MM
Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1040-1050. PubMed ID: 28332987
[TBL] [Abstract][Full Text] [Related]
32. Management and Outcome of Colorectal Cancer Liver Metastases in Elderly Patients: A Population-Based Study.
Booth CM; Nanji S; Wei X; Mackillop WJ
JAMA Oncol; 2015 Nov; 1(8):1111-9. PubMed ID: 26355283
[TBL] [Abstract][Full Text] [Related]
33. Outcomes of chemoradiotherapy in cervical cancer--the Western Australian experience.
Lim A; Sia S
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):1431-8. PubMed ID: 21640504
[TBL] [Abstract][Full Text] [Related]
34. A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer.
Xie X; Song K; Cui B; Jiang J; Yang X; Kong B
Int J Clin Oncol; 2018 Jun; 23(3):522-531. PubMed ID: 29299705
[TBL] [Abstract][Full Text] [Related]
35. [Survival analysis of cervical cancer patients].
Pardo C; Cendales R
Biomedica; 2009 Sep; 29(3):437-47. PubMed ID: 20436995
[TBL] [Abstract][Full Text] [Related]
36. The impact of age in the outcome of patients with advanced or recurrent cervical cancer after platinum-based chemotherapy.
Kastritis E; Bamias A; Bozas G; Koutsoukou V; Voulgaris Z; Vlahos G; Rodolakis A; Gika D; Papadimitriou C; Dimopoulos MA
Gynecol Oncol; 2007 Feb; 104(2):372-6. PubMed ID: 17030353
[TBL] [Abstract][Full Text] [Related]
37. Influence of histologic type and age on survival rates for invasive cervical carcinoma in Taiwan.
Chen RJ; Lin YH; Chen CA; Huang SC; Chow SN; Hsieh CY
Gynecol Oncol; 1999 May; 73(2):184-90. PubMed ID: 10329032
[TBL] [Abstract][Full Text] [Related]
38. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
Singh P; Tripcony L; Nicklin J
Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
[TBL] [Abstract][Full Text] [Related]
39. An evaluation of cervical cancer in women age sixty and over.
Fox KV; Shah CA; Swisher EM; Garcia RL; Mandel LS; Gray HJ; Swensen RE; Goff BA
Gynecol Oncol; 2008 Apr; 109(1):53-8. PubMed ID: 18255127
[TBL] [Abstract][Full Text] [Related]
40. Socioeconomic status and cervical cancer survival among older women: findings from the SEER-Medicare linked data cohorts.
Coker AL; Du XL; Fang S; Eggleston KS
Gynecol Oncol; 2006 Aug; 102(2):278-84. PubMed ID: 16434087
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
